Prestige Consumer Healthcare (NYSE:PBH) Stock Crosses Above Two Hundred Day Moving Average - Time to Sell?

Key Points

• Prestige Consumer Healthcare shares crossed above their 200-day moving average of $50.38, trading as high as $50.84 before last changing hands at $49.19.
• Analyst sentiment is mixed: ratings range from Strong Buy to Sell, resulting in a consensus “Hold” rating and an average price target of $67.67.
• The company exceeded quarterly expectations, reporting $0.98 in earnings per share versus a $0.89 estimate and revenue of $265.71 million, up 6.5% year over year; institutional investors own 99.95% of the stock.

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) shares crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $50.38 and traded as high as $50.84. Prestige Consumer Healthcare shares last traded at $49.1870, with a volume of 533,924 shares traded.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Weiss Ratings reiterated a "sell (d+)" rating on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 22nd. Zacks Research raised shares of Prestige Consumer Healthcare from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, September 30th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Prestige Consumer Healthcare has a consensus rating of "Hold" and an average price target of $67.67.

Prestige Consumer Healthcare Stock Up 1.6%

The company has a debt-to-equity ratio of 1.06, a current ratio of 3.23 and a quick ratio of 1.99. The firm has a 50-day moving average of $49.26 and a 200 day moving average of $50.38. The stock has a market capitalization of $2.33 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 1.52 and a beta of 0.34.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.98 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.09. Prestige Consumer Healthcare had a return on equity of 11.39% and a net margin of 15.57%. The firm had revenue of $265.71 million for the quarter, compared to analyst estimates of $253.02 million. During the same quarter in the previous year, the firm earned $0.90 EPS. The business's quarterly revenue was up 6.5% on a year-over-year basis. Prestige Consumer Healthcare has set its FY 2027 guidance at 4.550-4.650 EPS. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.56 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Several hedge funds and other institutional investors have recently made changes to their positions in PBH. Milestone Asset Management LLC acquired a new position in Prestige Consumer Healthcare during the third quarter worth $1,251,000. GAMMA Investing LLC increased its stake in shares of Prestige Consumer Healthcare by 22.5% during the 3rd quarter. GAMMA Investing LLC now owns 3,219 shares of the company's stock worth $148,000 after purchasing an additional 591 shares during the last quarter. Farther Finance Advisors LLC increased its stake in shares of Prestige Consumer Healthcare by 2,152.2% during the 3rd quarter. Farther Finance Advisors LLC now owns 7,117 shares of the company's stock worth $326,000 after purchasing an additional 6,801 shares during the last quarter. Congress Asset Management Co. acquired a new position in shares of Prestige Consumer Healthcare during the 3rd quarter worth about $7,515,000. Finally, Tidal Investments LLC raised its holdings in shares of Prestige Consumer Healthcare by 27.7% in the 2nd quarter. Tidal Investments LLC now owns 39,282 shares of the company's stock valued at $1,857,000 after purchasing an additional 8,531 shares during the period. 99.95% of the stock is owned by institutional investors.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc NYSE: PBH is a consumer healthcare company that develops, markets and distributes over-the-counter (OTC) products and household health-care brands. Its portfolio includes products for eye care, oral care, gastrointestinal health, pain relief, respiratory health, women's health, and other everyday health needs.

The company's brands include Dramamine, Bonine, BC, Goody's, Clear Eyes, TheraTears, Monistat, Summer's Eve, Vagisil, Luden's, Chloraseptic, Compound W, Fleet and Debrox.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.